Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Serono pays $44m to settle promotion of multiple sclerosis drug.
Tanne JH.
BMJ. 2011 May 10;342:d2922. doi: 10.1136/bmj.d2922. No abstract available.
Related citations
NICE rules out NHS prescription of fingolimod for multiple sclerosis.
Cohen D.
BMJ. 2011 Aug 10;343:d5117. doi: 10.1136/bmj.d5117. No abstract available.
Skin defect in a bedbound patient.
Reid AW, Shelley OP.
BMJ. 2011 May 18;342:d874. doi: 10.1136/bmj.d874. No abstract available.
NICE guidelines on multiple sclerosis are being ignored.
Hawkes N.
BMJ. 2011 Oct 11;343:d6525. doi: 10.1136/bmj.d6525. No abstract available.
Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden.
Bardage C, Persson I, Ortqvist A, Bergman U, Ludvigsson JF, Granath F.
BMJ. 2011 Oct 12;343:d5956. doi: 10.1136/bmj.d5956.
New partnership pumps pound 1m into stem cell research for multiple sclerosis.
Watts G.
BMJ. 2010 Jan 15;340:c292. doi: 10.1136/bmj.c292. No abstract available.
Doctor who sent patients for stem cell injections is accused of exploitation.
Dyer C.
BMJ. 2010 Jan 13;340:c197. doi: 10.1136/bmj.c197. No abstract available.
Stem cell treatments and multiple sclerosis.
Franklin RJ, Ffrench-Constant C.
BMJ. 2010 Mar 11;340:c1387. doi: 10.1136/bmj.c1387. No abstract available.
Doctor is found guilty of exploiting "desperate" MS patients.
BMJ. 2010 Apr 12;340:c2009. doi: 10.1136/bmj.c2009. No abstract available.
The multiple sclerosis risk sharing scheme.
Scolding N.
BMJ. 2010 Jun 3;340:c2882. doi: 10.1136/bmj.c2882. No abstract available.
Continuing the multiple sclerosis risk sharing scheme is unjustified.
McCabe C, Chilcott J, Claxton K, Tappenden P, Cooper C, Roberts J, Cooper N, Abrams K.
BMJ. 2010 Jun 3;340:c1786. doi: 10.1136/bmj.c1786. No abstract available.
Multiple sclerosis risk sharing scheme: a costly failure.
Raftery J.
BMJ. 2010 Jun 3;340:c1672. doi: 10.1136/bmj.c1672. No abstract available.
Commentary: Scheme has benefited patients.
Compston A.
BMJ. 2010 Jun 3;340:c2707. doi: 10.1136/bmj.c2707. No abstract available.
Commentary: Outcome measures were flawed.
Ebers GC.
BMJ. 2010 Jun 3;340:c2693. doi: 10.1136/bmj.c2693. No abstract available.
Cannabis based drug is licensed for spasticity in patients with MS.
Kmietowicz Z.
BMJ. 2010 Jun 22;340:c3363. doi: 10.1136/bmj.c3363. No abstract available.
MS risk sharing scheme. Response from chair of scientific advisory committee.
Lilford RJ.
BMJ. 2010 Jul 7;341:c3590. doi: 10.1136/bmj.c3590. No abstract available.
MS risk sharing scheme. Some clarification needed.
Richards RG.
BMJ. 2010 Jul 7;341:c3589. doi: 10.1136/bmj.c3589. No abstract available.
Stem cell therapy doctor exploited desperate patients, GMC finds.
BMJ. 2010 Sep 13;341:c5001. doi: 10.1136/bmj.c5001. No abstract available.
Stem cell therapy doctor struck off by the GMC.
BMJ. 2010 Sep 30;341:c5410. doi: 10.1136/bmj.c5410. No abstract available.
Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis.
Staples J, Ponsonby AL, Lim L.
BMJ. 2010 Apr 29;340:c1640. doi: 10.1136/bmj.c1640.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on